跳转至内容
Merck
CN
HomeSMC® High Sensitivity Immunoassay KitsAn Overview of SMC® Ultrasensitive Immunoassay Technology

An Overview of SMC® Ultrasensitive Immunoassay Technology

How can ultrasensitive immunoassay technology advance your studies? In this article, learn how SMC® technology can be used in research areas including immunology, cardiotoxicity, and neuroscience to provide more comprehensive biological insights by revealing signals that fall below the detection limits of traditional immunoassays.

Section Overview

What Is SMC® Technology?

SMC® technology is an advanced ultrasensitive immunoassay technology that gives researchers the power to detect biomarkers that were previously undetectable down to femtogram/mL levels. It provides an indispensable tool in the researcher’s arsenal to help move novel biology forward, fueling the discovery and development of new therapeutics. SMC® technology uses a basic sandwich immunoassay format utilizing two antibodies specific to the analyte of interest: a capture antibody coated on a magnetic bead or plate and a detection antibody conjugated to a fluorescent protein. Single or dual analyte analyses can be performed with the FemtoQuest™ system. Only SMC® immunoassay technology allows researchers to use both bead-based and plate-based methods, thus offering unmatched flexibility in assay design.

SMC® Technology Workflow

Traditional immunoassays have limitations such as matrix effects, dynamic range, and sensitivity that can impact the ability to accurately measure or even detect low abundant proteins. These limitations can lead to false positives or negatives, incorrect assumptions, and missed opportunities, overlooking critical early disease biomarkers. To overcome this, the patented SMC® technology combines a traditional sandwich ELISA immunoassay workflow with proprietary steps that enhance signal by disassociating the fluorescent-labeled antibody. Using this technique, SMC® technology can detect low-abundant biomarkers with unparalleled sensitivity and accuracy, measuring down to fg/mL levels. Researchers can detect, and monitor changes in, extremely low levels of established disease biomarkers such as cardiac troponin I and cytokines.

The SMC® technology workflow is described below. What distinguishes SMC® assays from traditional immunoassays is the elution step which breaks apart the immunoassay complex. The eluate, containing the fluorescent reporter molecule, is then transferred to the SMC® 384-well read plate. This removes other assay components like beads and unbound antibodies that could contribute to high background fluorescent signal. The plate is loaded into the FemtoQuest™ instrument where a laser excites the fluorescent-labeled detection antibody as it passes through a narrow interrogation window. Individual photons are captured by an avalanche photodiode and the signal is recorded. This allows for the digital quantification of individual molecules. Analyte concentrations in the unknown samples are calculated using the corresponding standard curve.

The steps in the SMC® Technology Workflow include:

Graphic showing yellow, magenta, and blue ovals representing analyte 1, analyte 2, and other proteins in a sample.

Sample Prep

Analyte(s) of interest in solution.

Illustration showing a yellow oval representing analyte 1 and a pink oval representing analyte 2, each bound to antibodies coated to a surface.

Capture analyte(s) on plate or bead.

Illustration showing a yellow oval representing analyte 1 and a pink oval representing analyte 2, each 'sandwiched' between an antibody coated to a surface and a fluorescent-labeled antibody.

Antibodies translate each biomarker into a signal.

Illustration showing disassociation of antibody/biomarker/fluorescent-labeled antibody complexes.

Complex is chemically broken apart.

Illustration depicting two fluorescent-labeled antibody/analyte complexes within a beige circle representing the interrogation window.

Sample is detected by laser and detection tags are counted.

The unique features of the SMC® immunoassay result in a reproducible signal and improved quantification of proteins in low abundance. With better precision, researchers can:

  • Quantify previously undetectable analytes
  • Better stratify sample populations
  • Gain insights into novel biological mechanisms
  • Leverage fewer data points for critical decision making
  • Accelerate drug discovery and development
  • Reduce program costs and improve productivity

Ultrasensitive Biomarker Detection Platform

SMC® technology offers an ultrasensitive biomarker detection platform with the flexible FemtoQuest™ system. Table 1 compares running assays on this platform to running traditional ELISAs.

Ancillary Equipment and Kits to Enhance the SMC® Workflow

To enhance the FemtoQuest™ platform, we also offer ancillary equipment and kits specifically for SMC® technology, such as:

Research Applications

Ultrasensitive immunoassays can enhance research in a variety of fields because the improved sensitivity allows researchers to dive deeper into their studies. Research applications of SMC® technology include the areas of:

Frequently Cited Advantages of SMC® Technology

SMC® technology provides maximum immunoassay performance while following a workflow very similar to traditional ELISA technology.

Traditional ELISA methodologies demonstrate limitations in sensitivity and dynamic range, typically require high sample volumes, and are susceptible to matrix effects. Combined, these factors reduce the utility of traditional ELISAs for the detection of low-abundant proteins and endogenous biomarker levels in healthy subjects, thus hampering statistical analysis among study groups. By adapting an ELISA workflow, SMC® technology achieves improved signal-to-noise ratios over traditional immunoassay technologies, thus providing quantification at both low and high levels of expression in one complete system. Digital counting of fluorescent events improves the assay sensitivity and extends the assay dynamic range beyond what can be achieved with traditional immunoassays.

Because SMC® immunoassay technology can reach fg/mL sensitivity ranges, this platform offers the ability to dilute pre-clinical samples, when only low sample volumes are available. 

Users are fully supported by Specialists, as well as dedicated technical support teams.

We understand the SMC® platform is an important investment for research labs and we are committed to ensuring the success of its users. Regardless of the types of assays being used, all SMC® users are fully supported by Specialists who have experience working with researchers from a broad range of lab types, including academic, government, biotech, pharma, CRO, and regulated labs.

The SMC® platform is a versatile system that can be used in multiple study types, including biomarker assessment, bioanalytical work such as pharmacokinetic and pharmacodynamic studies, and immunogenicity testing.

Complimenting a menu of off-the-shelf, verified assay kits, our Custom Assay Development and Innovation (CADI) team can be contracted to perform custom assay development and sample testing services at their site in St. Louis, MO, USA. Request more information about our custom services on our CADI page.

SMC® assays are available in bead-based formats and can be developed in both plate-based and bead-based formats by our CADI team.

The proprietary SMC® technology allows scientists to measure proteins with increased precision, enabling unparalleled quantification at low and high abundant levels of expression. The flexible SMC® immunoassay system acquires data from both plate-based assays and bead-based assays, providing a choice of format depending on budget and quantification requirements. Learn more about how we develop custom SMC® assays in our article on CADI services.

The SMC® 384-well read plate is pre-qualified and designed for optimal performance. It delivers reproducible results and supports consistent data generation across studies. This high-throughput platform allows researchers to perform an entire SMC® assay from sample prep through data analysis in one day.

FemtoQuest™ system can be integrated with the AAW™ Automated Assay Workstation to reduce hands-on time and ensure robustness and reproducibility.

Automation of SMC® immunoassays is desirable so that researchers can focus on other high-value activities and increase overall efficiency. The AAW™ automated assay workstation is a modular robotic liquid handler powered by Opentrons®, that is designed for high-throughput and technical workflows such as SMC® high sensitivity immunoassays. Automating SMC® immunoassays with the AAW™ automated assay workstation helps customers achieve key performance metrics while reducing manual intervention steps.

Integrated analysis with Belysa® curve fitting software.

The FemtoQuest™ system uses in-house developed software with optimized scan time and algorithms to improve variability, limit of detection and dynamic range for enhanced sample discrimination. The integration with the Belysa® Curve Fitting Software provides a user-friendly experience for data analysis.

For labs operating in a regulated environment, the FemtoQuest™ system generates a signal data stream that can be imported into Laboratory Management Systems, such as WATSON.

Tips and Tricks for Running SMC® Assays

Have questions about running SMC® assays? Check out helpful tips and tricks in our guide to high sensitivity biomarker analysis with SMC® technology.

Related Webinars

Publications Using SMC® Technology

See how researchers are using SMC® technology in the publications list below organized by research area.

For Research Use Only. Not For Use In Diagnostic Procedures.

Curious for more? Learn about the capabilities of our multiplex immunoassays on our MILLIPLEX® multiplex assay overview page.

Related Products

Loading

To see the most updated list of SMC® kits, visit SMC® High Sensitivity Immunoassay Kits.

登录以继续。

如要继续阅读,请登录或创建帐户。

暂无帐户?